Swedencare AB (publ) Share Price Nasdaq Stockholm
Stocks
SE0008294078
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.48B 347M 308M 288M 262M 494M 33.39B 501M 1.35B 17B 1.3B 1.27B 54.61B | P/E 2026 * |
23.8x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4.98B 496M 440M 412M 375M 706M 47.73B 716M 1.93B 24.31B 1.86B 1.82B 78.08B | EV / Sales 2026 * |
1.74x | EV / Sales 2027 * | 1.55x |
| Free-Float |
32.74% | Yield 2026 * |
2.02% | Yield 2027 * | 3.21% |
Last Transcript: Swedencare AB (publ)
| 1 day | -4.16% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 31/12/2013 | |
Jenny Graflind
CEO | Chief Executive Officer | 50 | 31/10/2019 |
Annie Bengtsson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 59 | 31/12/2025 | |
| Director/Board Member | 63 | 31/12/2018 | |
Johan Bergdahl
BRD | Director/Board Member | 56 | 31/12/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.16% | -5.47% | - | - | 349M | |
| -0.87% | -3.06% | +38.81% | +112.85% | 1,031B | |
| -2.04% | -4.26% | +39.29% | +67.03% | 638B | |
| -0.40% | -1.53% | +6.83% | +76.10% | 462B | |
| -1.20% | -2.87% | +59.47% | +40.16% | 359B | |
| -0.03% | -3.96% | +23.63% | +40.70% | 335B | |
| -1.58% | -0.76% | +13.50% | +26.44% | 273B | |
| -2.02% | -2.97% | -3.25% | +9.88% | 253B | |
| -2.30% | +1.14% | +37.57% | +54.20% | 228B | |
| -0.79% | -1.08% | +33.22% | +99.82% | 185B | |
| Average | -1.53% | -0.36% | +27.67% | +58.58% | 418.21B | |
| Weighted average by Cap. | -1.15% | -0.35% | +30.57% | +69.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.86B 284M 253M 236M 215M 405M 27.38B 411M 1.11B 13.94B 1.07B 1.04B 44.78B | 3.13B 311M 276M 259M 236M 444M 29.97B 450M 1.21B 15.26B 1.17B 1.14B 49.02B |
| Net income | 129M 12.81M 11.38M 10.64M 9.7M 18.26M 1.23B 18.51M 49.84M 628M 48.1M 47.06M 2.02B | 217M 21.62M 19.2M 17.96M 16.36M 30.8M 2.08B 31.23M 84.09M 1.06B 81.16M 79.4M 3.4B |
| Net Debt | 1.5B 149M 132M 124M 113M 212M 14.34B 215M 579M 7.3B 559M 547M 23.46B | 1.38B 137M 122M 114M 104M 195M 13.18B 198M 532M 6.71B 514M 503M 21.55B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
